Valsartan Lawyers To Be Appointed To Leadership Position After Next MDL Conference
A federal judge is expected to select attorneys for leadership positions in valsartan recall litigation by the end of the month.…
«
»
A federal judge is expected to select attorneys for leadership positions in valsartan recall litigation by the end of the month.…
A class action lawsuit calls for the makers of valsartan tablets recalled due to cancer-causing impurities to pay for medical monitoring for consumers who unknowingly consumed their tainted drugs.…
Plaintiffs can now file valsartan recall lawsuits over cancer injuries directly with the MDL court in New Jersey…
A valsartan lawsuit accuses recalled generic versions of the drug, tainted with known carcinogens, for a colon cancer diagnosis.…
The FDA is providing a list of 40 blood pressure medications it says are free of cancer-causing impurities, but warns that shortages will increase beyond valsartan.…
A valsartan lawsuit claims the presence of cancer-causing impurities led to the development of liver cancer in the plaintiff, and says the drugs are technically unapproved medications.
…
The initial status conference for federal valsartan recall litigation is scheduled for March 27.…
A new editorial looks at the massive number of valsartan recalls as a stress test of the U.S. drug supply chain and call for the FDA and pharmacies to learn from the experience.…
The FDA has fast-tracked approval of a new generic valsartan tablet in the face of shortages due to recalls over cancer-causing impurities.…
Deadlines in federal valsartan recall lawsuits have been suspended until the first initial status conference later this month as part of the recently-formed MDL.…